| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |